Shubham Pant, MD

Articles by Shubham Pant, MD

Shubham Pant, MDPancreatic Cancer | March 13, 2025

Dr. Pant shared updates on a phase 1b dose escalation trial of gemcitabine, nab-paclitaxel, and lixumistat.

Shubham Pant, MDBile Duct Cancer | January 27, 2025

Dr. Pant offered insights on the key findings of zanidatamab's efficacy and safety in HER2-positive BTC.

Shubham Pant, MDBile Duct Cancer | January 18, 2025

Dr. Pant describes the improved DOR and median OS seen with the treatment, and discusses the ongoing phase 3 trial.